MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 338 filers reported holding MEDIVATION INC in Q4 2014. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $213,705,000 | +26.3% | 3,544,185 | -3.7% | 0.02% | +27.8% |
| Q1 2016 | $169,211,000 | +2.3% | 3,680,057 | +7.5% | 0.02% | 0.0% |
| Q4 2015 | $165,414,000 | +22.3% | 3,421,851 | +7.6% | 0.02% | +12.5% |
| Q3 2015 | $135,242,000 | -18.2% | 3,181,332 | +119.8% | 0.02% | -11.1% |
| Q2 2015 | $165,331,000 | -10.0% | 1,447,667 | +1.7% | 0.02% | -5.3% |
| Q1 2015 | $183,733,000 | +33.3% | 1,423,477 | +2.9% | 0.02% | +35.7% |
| Q4 2014 | $137,830,000 | +33.6% | 1,383,600 | +32.6% | 0.01% | +27.3% |
| Q3 2014 | $103,136,000 | +25.1% | 1,043,154 | -2.5% | 0.01% | +22.2% |
| Q2 2014 | $82,450,000 | +11.9% | 1,069,681 | -6.6% | 0.01% | +12.5% |
| Q1 2014 | $73,706,000 | -47.5% | 1,145,013 | -53.6% | 0.01% | -11.1% |
| Q4 2013 | $140,520,000 | +90.5% | 2,468,437 | +100.6% | 0.01% | 0.0% |
| Q3 2013 | $73,749,000 | +4.4% | 1,230,321 | -14.3% | 0.01% | 0.0% |
| Q2 2013 | $70,638,000 | – | 1,435,773 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |